Duobody-CD3xCD20 Shows Unique and Potent Preclinical Anti-Tumor Activity in Vitro and In Vivo, and Is Being Evaluated Clinically in Patients with B-Cell Malignancies

Author(s):
Hiemstra, I.H.; Engelberts, P.J.; Jong, B. de; Schuurhuis, D.H.; Salcedo, T.W.; Verploegen, S.; Zee, M. van der; Gerritsen, A.F.; Losic, N.; Horbach, S.; Oliveri, R.; Bueren, J.J.L. van; Usher, P.A.; Schuurman, J.; Parren, P.W.H.I. (0000-0002-4365-3859); Breij, E.C.W.
Published
2018
Publication type
Other
Date issued
2018-11-29
Language
English
Publisher
AMER SOC HEMATOLOGY
hdl
1887/121520
doi
10.1182/blood-2018-99-115957